What Is Named Patient Supply?
Named Patient Supply is a regulatory pathway that allows patients to access medicines not yet approved or commercially available in their country. At GNH India, we partner with leading global manufacturers and health authorities to secure these critical therapies on a patient‑by‑patient basis.
Whether it’s an investigational oncology drug, a rare‑disease biologic, or a specialized orphan therapy, our team handles all regulatory filings, quality checks, and logistics to bring you the treatment you need—fast and fully compliant.
How It Works
Our end‑to‑end Named Patient Supply service is designed to be transparent, efficient, and patient‑centric. Here’s our six‑step process:
Initial Consultation: You or your physician shares the patient’s medical history, diagnosis, and prescription.
Regulatory Assessment: We prepare and submit all necessary documentation to the local health authority under the Named Patient regulations.
Manufacturer Coordination: We liaise with approved global manufacturers to reserve and quality‑test the required batch.
Import‑Export Clearance: Our logistics team secures all customs and import permits, including cold‑chain management if needed.
Secure Delivery: We arrange temperature‑controlled shipping directly to your clinic or hospital pharmacy.
Ongoing Support: Post‑delivery, we provide pharmacovigilance reporting and handle any regulatory queries.
Why Choose GNH India?
With over 20 years of experience in pharmaceutical distribution and regulatory affairs, GNH India offers:
- Deep expertise in Named Patient and Compassionate Use programs
- Dedicated regulatory affairs specialists
- Global network of vetted manufacturers
- End‑to‑end cold‑chain logistics
- 24/7 customer support and pharmacovigilance
- Fully compliant with CDSCO, EMA, FDA, and other authorities